Prediction of Pancreatogenic Diabetes After Partial Resection of the Pancreas
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- Development of pancreatogenic diabetes
研究概览
简要总结
The primary aim of the study is to identify clinical, laboratory, imaging, and pathohistological risk factors for the development of pancreatogenic diabetes after partial resection of the pancreas (PRP) and, based on these, to build a predictive model that would enable reliable and accurate identification of patients who will develop pancreatogenic diabetes. A review of the literature shows that there is currently no validated tool available in clinical practice for identifying patients at risk of this type of diabetes after PRP. Etiological differences between type 2 diabetes and pancreatogenic diabetes often lead to late diagnosis, limiting opportunities for timely intervention. The development of a comprehensive predictive model would contribute to a better understanding of the pathophysiology of pancreatogenic diabetes, enable the identification of patients at risk, facilitate tailored clinical monitoring, and allow the implementation of targeted preventive or therapeutic measures in the perioperative period.
Based on a review of the literature and clinical observations, the investigators formulated the following hypotheses:
H1: Clinical, laboratory, imaging, and pathohistological variables are independently associated with the development of pancreatogenic diabetes after partial pancreatic resection.
H2: A predictive model that allows reliable and accurate identification of patients who will develop pancreatogenic diabetes can be build based on the identified variables (H1).
H3: A comprehensive predictive model in the perioperative period allows more precise identification of patients who will develop pancreatogenic diabetes, and thus more effective risk stratification compared to the use of individual risk factors (variables).
Based on the reviewed literature and our own clinical observations, this constitutes an original contribution to science. The investigators expect that the research will identify key clinical, laboratory, imaging, and pathohistological factors associated with the development of pancreatogenic diabetes after partial pancreatic resection. The development of a clinically useful predictive model that will allow individual risk assessment for the development of pancreatogenic diabetes in patients after partial pancreatic resection is anticipated. A similar comprehensive model has not yet been described in the accessible literature. The research will contribute to a better understanding of metabolic changes and will enable the identification of patients who will develop pancreatogenic diabetes after partial pancreatic resection. The results of the study could provide a basis for improved perioperative monitoring of these patients in the field of pancreatogenic diabetes.
详细描述
Research Protocol:
At the first preoperative examination in the Abdominal Surgery Outpatient Clinic of the University Medical Centre Ljubljana, inclusion and exclusion criteria for the study will be considered and the suitable patients will recieve oral and written explanation about the purpuse, course and nature of the study (day 0). After obtaining written consent from patients, the investigators will collect demographic data (gender, age), data from each participant's medical records (associated diseases, list of regular therapies, etc.) and clinical data on the underlying pancreatic disease (including abdominal CT findings). The anthropometric measurements (body weight and hight), vital sign measurements (blood pressure, pulse) and laboratory markers, that are routinely analyzed before the PRP, will be determined. Additionally, HbA1c, serum fasting insulin and C-peptide will be measured and an oral glucose tolerance test (OGTT) administered,according to a standardized procedure with a standard fasting period. The degree of insulin resistance (HOMA-IR and CGR) will be assessed. Blood analyses will be conducted at the Laboratory of the Clinical Institute of Clinical Chemistry and Biochemistry and the Clinic of Nuclear Medicine of the University Medical Centre Ljubljana.
According to clinical indications, the participants will then be called for the PRP (e.g., distal pancreatectomy, pancreatoduodenectomy, or other form of partial resection), which will be carried out at the Clinical Department of Abdominal Surgery at the University Medical Center in Ljubljana. The pathological examination of the removed part of the pancreas will be undertaken as part of the routine postoperative analysis at the Institute of Pathology, Faculty of Medicine, University of Ljubljana. In the removed pancreatic tissue the proportion of β cells, fat, and fibrous tissue will be assessed during patohistological analysis.
Three months after PRP, which coincides with the regular postoperative check-up with the abdominal surgeon, there will be a follow-up examination in Abdominal Surgery Outpatient Clinic of the University Medical Centre Ljubljana. The same data will be collected as before PRP and HOMA-IR and CGR recalculated. Likewise, patients will undergo a follow-up abdominal CT as part of routine clinical practice, where using a computer program, the volume of tissue removed, as well as the fat and fibrous tissue will be compared to the examination before the PRP. This time point after the PRP was chosen as clinically feasible and methodologically suitable for assessing early postoperative endocrine dysfunction of the pancreas, as it allows monitoring of metabolic changes after resection with minimal additional burden on the patients. The three-month follow-up also reduces the impact of long-term confounding factors, such as the progression of malignant disease, cachexia, prolonged systemic oncological treatment, and loss of patients from follow-up. When interpreting the results, the investigators will nevertheless take into account postoperative complications, the introduction of chemotherapy, the use of glucocorticoids, nutritional status, and other factors that can affect glucose metabolism.
All the obtained data will be statistically analyzed, and a statistical predictive model for the occurrence of pancreatogenic diabetes after partial pancreatic resection will be constructed.To reduce the possibility of variability between different observers, histopathological analyses will be performed by one pathologist and CT analyses by one radiologist.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age ≥ 18 years
- •planned partial resection of the pancreas
- •absence of known diabetes before the procedure
- •absence of known borderline basal glycemia before the procedure
- •absence of impaired glucose tolerance before the procedure
- •signed written informed consent
排除标准
- •known diabetes mellitus before the procedure
- •known borderline basal glycemia before the procedure
- •impaired glucose tolerance before the procedure
- •inability to provide informed consent
- •withdrawal of consent during the course of the study
- •total resection of the pancreas
- •a subsequent decision for conservative treatment (based on clinical characteristics at the time of the surgical procedure)
研究组 & 干预措施
Patients Undergoing Partial Pancreatectomy
This cohort includes adult patients undergoing partial pancreatectomy for various pancreatic diseases. Inclusion criteria: age ≥ 18 years, planned partial resection of the pancreas, absence of known diabetes mellitus, borderline basal glycemia, or impaired glucose tolerance before the procedure, signed written informed consent. Criteria for non-inclusion: known diabetes, borderline basal glycemia or impaired glucose tolerance before surgery (even if confirmed by OGTT before the procedure), inability to provide informed consent.
Participants are prospectively followed to assess metabolic changes and the development of pancreatogenic diabetes. No experimental interventions are administered as part of the study; all patients receive standard clinical care. Data collection includes clinical, biochemical, imaging, and histopathological parameters.
结局指标
主要结局
Development of pancreatogenic diabetes
时间窗: 3 months after surgery
Pancreatogenic diabetes will be assessed based on standard diagnostic criteria using oral glucose tolerance test.
次要结局
- Prediction Model Performance(At 3 months after surgery)
- Patohistology of the Pancreas(immediately after the resection of the pancreas)
- CT of the abdomen(before the resection of the pancreas and 3 months after the resection)
研究者
Jasna Klen
Dr. Jasna Klen, MD, PhD, Associate Professor of Internal Medicine
University Medical Centre Ljubljana
